The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Med.
Sec. Precision Medicine
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1478842
This article is part of the Research Topic Head and Neck Squamous Cell Carcinoma: Navigating the Dawn of Personalized Medicine View all articles
Individualized treatment recommendations for patients with locally advanced head and neck squamous cell carcinoma utilizing deep learning
Provisionally accepted- Tongji University, Shanghai, China
The conventional treatment for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) patients is surgery, and the efficacy of definitive chemoradiotherapy (CRT) remains controversial.Objective: To evaluate the ability of deep learning (DL) models to identify patients with LA-HNSCC who can achieve organ preservation through definite CRT and provide individualized adjuvant treatment recommendations for patients who are better suited for surgery.Methods: Five models were developed for treatment recommendation. Their performance was assessed by comparing the difference in overall survival between patients whose actual treatment met the model recommendations and those who did not. Inverse probability treatment weighting (IPTW) was used to reduce bias. The effect of characteristics on treatment plan selection was quantified through causal inference.Results: 7,376 patients with LA-HNSCC were enrolled. Balanced Individual Treatment Effect for Survival data (BITES) performed best in both CRT recommendation (IPTW-adjusted hazard ratio (HR): 0.84, 95% confidence interval (CI), 0.72-0.98) and adjuvant therapy recommendation (IPTW-adjusted HR: 0.77, 95% CI, 0.61-0.85), which was better than other models and the National Comprehensive Cancer Network guidelines (IPTW-adjusted HR: 0.87, 95% CI, 0.73-0.96).BITES can select the most suitable treatment option for an individual patient from the three most common treatment options. DL models allow for the establishment of a valid and reliable treatment recommendation system with quantitative evidence.
Keywords: Head and neck squamous cell carcinoma, Chemoradiotherapy, deep learning, causal inference, precise medicine
Received: 11 Aug 2024; Accepted: 28 Nov 2024.
Copyright: © 2024 Zhang, Zhu, Shi, Wu, Cao, Huang, Ai and Su. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jiansheng Su, Tongji University, Shanghai, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.